Brief: Implantica Q1 Operating Loss Widens To EUR 2.3 Mln
12/05/2021 07:24
May 12 (Reuters) - Implantica AG 8IM1q.F :
* Q1 NET SALES AMOUNTED TO TEUR 82 (23)
* Q1 OPERATING LOSS (EBIT) INCREASED TO TEUR 2,279 (1,397)
Source text for Eikon: ID:nWkr4KLNGX
Further company coverage: 8IM1q.F
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Implantica AG
See all newsBrief: Implantica Q1 Operating Loss At EUR 3.9 Mln
Brief: Implantica Gives Final Response To FDA For PMA Application
Brief: Implantica Announces Adoption Of Refluxstop At Careggi University Hospital
Brief: Implantica - FDA Provides Feedback On Refluxstop PMA Module 3
Brief: Implantica Says FDA Provides Favorable Feedback On Refluxstop Pma Module 3